Update – 1st Quarter 2016

This presentation is made to provide information. No representation or warranty is made as tothe fairness, accuracy, completeness or correctness of the information, opinions and conclusionscontained within this presentation. All information including business forward plans in thispresentation should not be considered as a recommendation in relation to holding purchasing orselling shares in any jurisdiction. No copy or use of this presentation should occur without thepermission of PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK.

Disclaimer

INTRODUCTION

HIGHLIGHTS (IDR Bn)

Q1'16 Q1'15

Unaudited Unaudited

Net Sales 608 509 19.4%

Operating Income 149 138 7.6%

% Margin 24.5% 27.2% -2.7%

Net Income 125 118 6.3%

Total Assets 2,918 2,906 0.4%

Total Liabilities 223 153 45.3%

Total Equity 2,695 2,753 -2.1%

Woriking Capital 1,602 1,689 -5.1%

Current Ratio 8.4 12.4 -4.0

Cash Conversion Cycle 99 85 13.2

∆

MILESTONES

1940 1984

The company initially was a domestic herbalmedicine industry managed by Mrs. RahmatSulistio in Yogyakarta.

The production process was moved toSemarang, and an unpretentious companywas founded with the name SIDO MUNCULwhich means “a dream come true” with itsfirst factory located in Jl. Mlaten Trenggulun,Semarang.

1951 1970

The limited partnership was formedunder the name CV Industri Jamu &Farmasi Sido Muncul.

The factory was moved to LingkunganIndustri Kecil Semarang. The plant beganto be equipped with modern machinery.

Establishment of herbal medicineindustry turned into a Limited Companyunder the name of PT Industri Jamu danFarmasi Sido Muncul.

1975

Cornerstone-laying was held for theconstruction of a new, bigger and moremodern factory in Klepu, Ungaran by SriSultan Hamengkubuwono X and witnessed byDirector General of Food and DrugAdministration.

1997

The new factory is located in Klepu, subBergas, Ungaran with an area of about 30hectares..

2000

Sido Muncul conducted initial publicoffering of 1,500,000,000 shares withthe issue price of Rp 580.- per share.

2013

PT Berlico Mulia Farma joined the SidoMuncul Group, expanding Sido Muncul’sbusiness in pharmaceutical industry.

2014

The expansion of extraction plantof PT Semarang Herbal Indo Plantwas completed and fullyoperational.

2015

KEY ACHIVEMENTS

GOLD CHAMPION – INDONESIA WOW BRAND 2015 COMMON GOLD – BEST BRAND AWARD

NUSANTARA CSR AWARD – LA TOFFI SCHOOL OF CSR CORPORATE IMAGE AWARD 2015

BUSINESS OVERVIEW

PRODUCT PORTFOLIO

HERBAL&

SUPPLEMENT

FOOD&

BEVERAGES

PHARMACEUTICAL

Medan

Batam

PadangBangka

Belitung

Palembang

Bandar Lampung

Bengkulu

Jambi

Samarinda

Tarakan

Pontianak

Ketapang

Banjarmasin

Manado

GorontaloPalu

Kendari

Makassar

Ambon

Tobelo

Ternate

BiakSorong

Manokwari

Nabire

Timika

Jayapura

Merauke

Atambua

KupangSumbawa

LombokBali

Jakarta

Surabaya

YogyakartaSolo

Cilacap

Tangerang

Purwakarta

Cilacap

Madura

Jombang

DISTRIBUTION NETWORK

PT Muncul Mekar has 115 distributorsthroughout Indonesia and also expands itscooperation with several national modernoutlets and pharmaceutical wholesalers

TraditionalTrade

ModernOutlet

MedicalChannel/Distributor

West EastCentral

Wholesaler, Supermarket, Retail

Customers

PLANT EXPANSIONPT SEMARANG HERBAL INDO PLANT

The expansion of new extractionplant was finished. The new plantincreases the herbs extractioncapacity up to three times fromcurrent capacity, 4,500 kg/day to13,500 kg/day.

PLANT EXPANSIONSIDO MUNCUL

The new production facilities ofliquid herbal medicine is expected tobe completed by 2017. The newfacilities will increase theproduction capacity twice fromcurrent capacity

FINANCIAL OVERVIEW

276.8 352.1

211.3

236.0 21.3

20.1

Q1'15(Unaudited)

Q1'16(Unaudited)

Herbal & Supplement

57.9%

Food & Beverage

38.8%

Pharmacies3.3%

SALES (IDR Bn)

SALES MIX

509.4

608.2

Consolidated+19.4%

Pharmacies-5.6% (YoY)

Food & Beverages+11.7% (YoY)

Herbal & Supplement+27.2% (YoY)

138.4 148.9

27.2%24.5%

Q1'15(Unaudited)

Q1'16(Unaudited)

Operating Income Operating Margin

6.6%11.1%

4.4%

4.2%

Q1'15(Unaudited)

Q1'16(Unaudited)

Selling & Marketing General & Administrative

194.6

241.7

38.2% 39.7%

Q1'15(Unaudited)

Q1'16(Unaudited)

Gross Profit Gross Profit Margin

OPERATING PERFORMANCE (IDR Bn)

OPERATING EXPENSES TO SALES

GROSS PROFIT

OPERATING INCOMEConsolidated+24.2%

Consolidated+7.6%

2724 25

99%85% 84%

2013 2014 2015

Dividend per Share % Payout

118.0 125.4

23.2%20.6%

Q1'15(Unaudited)

Q1'16(Unaudited)

Net Income Net Profit Margin

30.6%27.5%

Q1'15(Unaudited)

Q1'16(Unaudited)

NET EARNINGS (IDR Bn)

NET INCOME

DIVIDEND

EBITDA MARGIN

Consolidated+6.3%

0.0 0.0 0.0 0.0

2013(Audited)

2014(Audited)

2015(Audited)

Q1'16(Unaudited)

79 78 86

99

2013(Audited)

2014(Audited)

2015(Audited)

Q1'16(Unaudited)

FINANCIAL POSITION (IDR Bn)

ASSETS & EQUITY

CASH CONVERSION

DEBT POSITION

2,955

2,821 2,796

2,918

2,614 2,625 2,598

2,695

2013(Audited)

2014(Audited)

2015(Audited)

Q1'16(Unaudited)

Assets Equity

REMAINING IPO PROCEEDS (IDR Bn)

168.08

48.20 10.54

226.82

Sido Muncul Muncul Mekar InformationTechnology

Total 2016/2017

APPENDICES

Main Office:

Gedung Menara Suara Merdeka Lantai 16

Jl Pandanaran No.30

Semarang 50134, Indonesia

Phone: (+6224) 7692-8811

Fax: (+6224) 7692-8815

Factory:

Jl Soekarno Hatta km 28

Kecamatan Bergas, Klepu

Semarang 50552, Indonesia

Phone: (+62298) 523-515

Fax: (+62298) 523-509

Website : www.sidomuncul.com

SIDO STRUCTURE

KELUARGAHIDAYAT

MASYARAKAT

81,00% 17,61%

99,99% 99,99% 99,99%

TREASURI

1,39%

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

in IDR Mn Q1'16 2015

Unaudited Audited

Current Assets

Cash and Cash Equivalents 813,407 836,975 -2.8%

Time Deposits 190,000 190,000 0.0%

Trade Receivables 400,469 335,600 19.3%

Inventories - Net 327,496 264,982 23.6%

Others 88,368 79,882 10.6%

Total Current Assets 1,819,740 1,707,439 6.6%

Total Non-current Assets 1,098,373 1,088,672 0.9%

TOTAL ASSETS 2,918,113 2,796,111 4.4%

∆

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

in IDR Mn Q1'16 2015

Unaudited Audited

Trade Payables 167,421 147,753 13.3%

Other Payables 5,869 10,532 -44.3%

Taxes Payable 34,148 21,475 59.0%

Accrued Expenses 8,312 3,297 152.1%

Others 1,632 1,003 62.7%

Total Current Liabilities 217,382 184,060 18.1%

Total Non-current Liabilites 5,449 13,737 -60.3%

TOTAL LIABILITIES 222,831 197,797 12.7%

EQUITY

Equity Attributable to Owners of the Parent Entity 2,695,275 2,598,307 3.7%

Non-controlling Interest 7 7 0.0%

TOTAL EQUITY 2,695,282 2,598,314 3.7%

TOTAL LIABILITIES AND EQUITY 2,918,113 2,796,111 4.4%

∆

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

in IDR Mn Q1'16 Q1'15

Unaudited Unaudited

Sales 608,243 509,417 19.4%

Cost of Good Sold 366,568 314,799 16.4%

Gross Profit 241,675 194,618 24.2%

% Margin 39.7% 38.2% 1.5%

Sales and Marketing Expenses 67,423 33,610 100.6%

General and Administrative Expenses 25,385 22,609 12.3%

Operating Income 148,867 138,399 7.6%

% Margin 24.5% 27.2% -2.7%

Other Finance Income 14,100 15,037 -6.2%

Other Finance Expenses 680 284 139.4%

Other Operating Income 1,319 2,263 -41.7%

Other Operating Expenses 419 1,273 -67.1%

Income Before Tax 163,187 154,142 5.9%

% Margin 26.8% 30.3% -3.4%

Income Tax Expenses 37,777 36,116 4.6%

Net Income for the Year 125,410 118,026 6.3%

% Margin 20.6% 23.2% -2.6%

Other Comprehensive Income (Loss) 0.0%

Total Comprehensive Income for the Year 125,410 118,026 6.3%

% Margin 20.6% 23.2% -2.6%

∆

CONSOLIDATED STATEMENTS OF CASH FLOWS

in IDR Mn Q1'16 Q1'15

Unaudited Unaudited

Cash Flows From Operating Activities 32,339 131,872

Cash Flows From Investing Activities (27,390) (94,527)

Cash Flows From Financing Activities (28,442)

Net Increase (Decrease) in Cash and Cash Equivalents (23,493) 37,345

Effect of Changes in Foreign Exchange Rate (75) 486

Cash and Cash Equivalents At the Beginning of the Year 836,975 864,791

Cash and Cash Equivalents At the End of the Year 813,407 902,622